In HCC murine model, curcumin significantly enhanced sorafenib activity, increased the amount of CD4+ T-cells and NK-cells, down-regulated p-PI3K/p-Akt, HIF1α, FASN, SREBP1, and CPT1a. Here, AKT1 is linked to hepatocellular carcinoma.